---
title: "Abbott to Pay $385 Million to Resolve US Infant Formula Claims"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298954924.md"
description: "Abbott Laboratories agreed to pay $385 million to settle US allegations over poor manufacturing practices at two facilities, including one tied to an investigation of a contaminated plant that made powder infant formula, according to Bloomberg."
datetime: "2026-09-14T18:55:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298954924.md)
  - [en](https://longbridge.com/en/news/298954924.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298954924.md)
generator: "portal-rs"
---

# Abbott to Pay $385 Million to Resolve US Infant Formula Claims

Abbott Laboratories agreed to pay $385 million to settle US allegations over poor manufacturing practices at two facilities, including one tied to an investigation of a contaminated plant that made powder infant formula, according to Bloomberg.

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [Abbott agrees to settle DOJ lawsuit over baby formula plant contamination](https://longbridge.com/en/news/299081753.md)
- [Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall | ABT Stock News](https://longbridge.com/en/news/298942114.md)
- [Micron Q4 Earnings Preview: Why Wells Fargo Cuts Price Target by 8% But Raises EPS Estimates](https://longbridge.com/en/news/299895673.md)
- [Nvidia’s Last Quarter Was Nearly Perfect. One Number in the Fine Print Wasn’t.](https://longbridge.com/en/news/299889479.md)
- [Why Did SanDisk Stock Surge 6%? Rosenblatt Initiates With Buy as AI Storage Demand Keeps Heating Up](https://longbridge.com/en/news/299852158.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**